The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness

Drug and Alcohol Review

Volumn 33, Issue 1, 2014, Pages 78-85

  Filia, Sacha L ^a   Baker, Amanda L ^b   Gurvich, Caroline T ^a   Richmond, Robyn ^c   Kulkarni, Jayashri ^a  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gender differences; Perceived risk and benefits; Severe mental illness; Smoking; Smoking cessation

Indexed keywords

ADULT; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; PSYCHOLOGY; PSYCHOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING CESSATION; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SEX FACTORS; SMOKING CESSATION; YOUNG ADULT;

EID: 84891912549     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12091     Document Type: Article

References (26)

1. Australian Institute of Health and Welfare (AIHW). Australia's health 2012. Canberra: AIHW, 2012. Australia's health no. 13. Cat. no. AUS 156.
2. Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, Castle D. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Aust N Z J Psychiatry 2012;46:851-863.
3. Hennekans CH, Hennekans AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121.
4. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012;25:83-88.
5. Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011;131:101-104.
6. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45:21-28.
7. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction 2009;104:719-733.
8. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010;105:1176-1189.
9. Williams JM, Anthenelli RM, Morris CD, etal. A randomised, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2012;73:654-660.
10. McKee SA, O'Malley SS, Salovey P, Krishnan-Sarin S, Mazure CM. Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav 2005;30:423-435.
11. Toll BA, Salovey P, O'Malley SS, Mazure CM, Latimer A, McKee SA. Message framing for smoking cessation: the interaction of risk perceptions and gender. Nicotine Tob Res 2008;10:195-200.
12. Weinberger AH, Mazure CM, McKee SA. Perceived risks and benefits of quitting smoking in non-treatment seekers. Addict Res Theory 2010;18:456-463.
13. Baker A, Kay-Lambkin FJ, Richmond R, etal. Healthy lifestyle intervention for people with severe mental disorders. Ment Health Subst Use 2011;4:144-157.
14. Baker A, Kay-Lambkin FJ, Richmond R, etal. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders. BMC Public Health 2011;11:10.
15. Castle DJ, Jablensky A, McGrath JJ, etal. The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol Med 2006;36:69-80.
16. Sheehan DV, Lecrubier Y, Sheehan KH, etal. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.
17. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87:733-742.
18. Fagerstrom KO, Kunze M, Schoberberger R, etal. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control 1996;5:52-56.
19. Filia SL, Baker AL, Gurvich CT, Richmond R, Lewin TJ, Kulkarni J. Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention. Psychiatry Res 2013. Manuscript under review.
20. Switaj P, Anczewska M, Chrostek A, etal. Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatry 2012;12:193.
21. Kulkarni J, de Castella AR, Filia KM, etal. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes. Aust N Z J Psychiatry 2007;41:969-979.
22. Cosgrove KP, Esterlis I, McKee SA, etal. Sex differences in availability of beta2-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry 2012;69:418-427.
23. Kulkarni J, Hayes E, Gavrilidis E. Hormones and schizophrenia. Curr Opin Psychiatry 2012;25:89-95.
24. Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ. Perceptions of anti-smoking public health campaigns among people with psychotic disorders. Ment Health Subst Use 2011;4:105-115.
25. Filia SL, Baker AL, Richmond R, etal. Health behaviour risk factors for coronary heart disease (CHD) in smokers with a psychotic disorder: baseline results. Ment Health Subst Use 2011;4:158-171.
26. Perkins KA. Smoking cessation in women. CNS Drugs 2001;15:391-411.